about
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug ...
Read More
11.14
0.12
(1.09%)
170.2K
XNAS Volume
XNAS 16 Jul, 2025 10:42 AM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Delcath Systems Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..